XRAY
DENTSPLY·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
High Gross Profit Margin
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About XRAY
Dentsply Sirona Inc.
The world’s largest manufacturer of professional dental products and technologies
Healthcare Equipment and Supplies
--
08/14/1987
NASDAQ Stock Exchange
14,000
12-31
Common stock
13320 Ballantyne Corporate Place, Charlotte, North Carolina 28277-3607
--
DENTSPLY SIRONA Inc., a Delaware corporation. The company is the world's largest manufacturer of professional dental products and technologies, with 137 years of innovation and service history in the dental industry, and a vision to improve oral health and incontinence care on a global scale. Dentsply Sirona develops, manufactures and markets comprehensive solutions, including technologically advanced dental equipment supported by cloud software solutions and dental products and healthcare consumables products in the areas of urology and enterology under a strong portfolio of world-class brands. Dentsply Sirona's products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dental services.
Earnings Call
Q1/2025
Estimate EPS0.3
Actual EPS0.43
Estimate Revenue853.91M
Actual Revenue879.00M
Dentsply Sirona's Q1 2025: Key Contradictions in Orthodontic Strategy, CFO Transition, and Tax Challenges
May 19,2025 09:18
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
XRAY has released its 2025 Q3 earnings. EPS was reported at 0.5, versus the expected 0.45, beating expectations. The chart below visualizes how XRAY has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
XRAY has released its 2025 Q3 earnings report, with revenue of 904.00M, reflecting a YoY change of -4.94%, and net profit of -428.00M, showing a YoY change of 13.54%. The Sankey diagram below clearly presents XRAY's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
